These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34958402)

  • 1. Influence of symptomatic periodontal disease on changes in skeletal bone density during medication therapy for osteoporosis in postmenopausal women: the Japanese Osteoporosis Intervention Trial (JOINT)-04 and JOINT-05.
    Taguchi A; Uemura Y; Tanaka S; Ohta H; Mori S; Hagino H; Shiraki M; Nakamura T; Soen S;
    Arch Osteoporos; 2021 Dec; 17(1):7. PubMed ID: 34958402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between self-reported periodontal status and skeletal bone mineral density in Japanese postmenopausal women.
    Taguchi A; Suei Y; Ohtsuka M; Nakamoto T; Lee K; Sanada M; Tsuda M; Ohama K; Tanimoto K; Bollen AM
    Menopause; 2005 Mar; 12(2):144-8. PubMed ID: 15772560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
    Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
    Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
    Miyauchi A; Dinavahi RV; Crittenden DB; Yang W; Maddox JC; Hamaya E; Nakamura Y; Libanati C; Grauer A; Shimauchi J
    Arch Osteoporos; 2019 Jun; 14(1):59. PubMed ID: 31168657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
    Välimäki MJ; Farrerons-Minguella J; Halse J; Kröger H; Maroni M; Mulder H; Muñoz-Torres M; Sääf M; Snorre Øfjord E
    Clin Ther; 2007 Sep; 29(9):1937-49. PubMed ID: 18035193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of periodontal disease and tooth loss to screen for low bone mineral density in Japanese women.
    Inagaki K; Kurosu Y; Yoshinari N; Noguchi T; Krall EA; Garcia RI
    Calcif Tissue Int; 2005 Jul; 77(1):9-14. PubMed ID: 16007480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between osteoporosis and severe periodontal attachment loss in postmenopausal women].
    Zhu J; Li JH; Yuan TT; He L; Liang YH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Mar; 55(3):159-164. PubMed ID: 32193911
    [No Abstract]   [Full Text] [Related]  

  • 9. Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia.
    Gorai I; Hattori S; Tanaka Y; Iwaoki Y
    J Bone Miner Metab; 2012 May; 30(3):349-58. PubMed ID: 22130786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal conditions in 70-year-old women with osteoporosis.
    Lundström A; Jendle J; Stenström B; Toss G; Ravald N
    Swed Dent J; 2001; 25(3):89-96. PubMed ID: 11813450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study.
    Ikeda Y; Iki M; Morita A; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    J Nutr; 2006 May; 136(5):1323-8. PubMed ID: 16614424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women.
    Wu XP; Liao EY; Huang G; Dai RC; Zhang H
    Calcif Tissue Int; 2003 Aug; 73(2):122-32. PubMed ID: 14565593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiresorptive bone medication on the effect of high-intensity resistance and impact training on osteoporotic fracture risk in postmenopausal women with low bone mass: protocol for the MEDEX-OP randomised controlled trial.
    Fischbacher M; Weeks BK; Beck BR
    BMJ Open; 2019 Sep; 9(9):e029895. PubMed ID: 31492784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.
    Boonen S; Marin F; Obermayer-Pietsch B; Simões ME; Barker C; Glass EV; Hadji P; Lyritis G; Oertel H; Nickelsen T; McCloskey EV;
    J Clin Endocrinol Metab; 2008 Mar; 93(3):852-60. PubMed ID: 18160462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between periodontal disease and bone mineral density in postmenopausal women: a cross sectional study.
    Sultan N; Rao J
    Med Oral Patol Oral Cir Bucal; 2011 May; 16(3):e440-7. PubMed ID: 21196826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
    Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
    Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
    Okubo N; Matsui S; Matsumoto T; Sugimoto T; Hosoi T; Osakabe T; Watanabe K; Takami H; Shiraki M; Nakamura T
    Calcif Tissue Int; 2020 Dec; 107(6):559-566. PubMed ID: 32839843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
    Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.